Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F22%3A00077413" target="_blank" >RIV/00159816:_____/22:00077413 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/22:00077413 RIV/00216224:14110/22:00128744
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S1052305722004980?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1052305722004980?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2022.106804" target="_blank" >10.1016/j.jstrokecerebrovasdis.2022.106804</a>
Alternative languages
Result language
angličtina
Original language name
Perceptions on basilar artery occlusion management in China versus other countries: Analysis of the after the BEST of BASICS (ABBA) survey
Original language description
Introduction: Uncertainty remains on the optimal management of basilar artery occlusion (BAO). Two large randomized controlled trials (RCTs) in 2019 and 2021 demonstrated neutral results with respect to the use of endovascular therapy (EVT) for BAO. This study aimed to understand regional variation in physicians' percep-tions towards the treatment of BAO as stratified by physician respondents from China versus outside China, prior to the publication of studies demonstrating a benefit of EVT for BAO. Methods: An international online survey was conducted of stroke neurologists and neurointerventionalists from January to March 2022. Sur-vey questions evaluated physician opinions toward the use of EVT in BAO, as well as the clinical and imaging features underlying treatment decisions. Respondents were dichotomized as either from China or from other countries and differences between groups were analyzed. Results: There were 1245 physician respondents across 73 countries of which 295 (23.7%) were from China. Compared to respond-ents from the rest of the world, respondents from China were more likely to be interventionalists (71.5% vs 35.0%; p < 0.0001). Overall, more than 95% of respond-ents believed that EVT was superior to medical therapy under certain circumstan-ces. Chinese respondents were more likely to believe that further RCTs were necessary than respondents from other countries (93.6% vs 76.2%; p < 0.0001). Chi-nese respondents were more likely to use advanced imaging in later time windows and use a premorbid mRS threshold of <2 for BAO selection to EVT. Conclusion: Most stroke physicians believe EVT is beneficial in selected patients with BAO. Clinical and imaging modality differences were observed in the selection criteria used for EVT. There was greater inclination to enroll all trial eligible patients in a BAO RCT by respondents from China as compared to other parts of the world.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30103 - Neurosciences (including psychophysiology)
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Stroke & Cerebrovascular Diseases
ISSN
1052-3057
e-ISSN
1532-8511
Volume of the periodical
31
Issue of the periodical within the volume
11
Country of publishing house
US - UNITED STATES
Number of pages
10
Pages from-to
106804
UT code for WoS article
000933363500001
EID of the result in the Scopus database
2-s2.0-85139336022